The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|May 2, 2019
- Pharmaceutical Technology-05-02-2019
- Volume 43
- Issue 5
New Pneumatic Presses
Wabash MPI and Carver’s PNP Series is a new line of pneumatic presses for a variety of applications, including composites molding, laminating, rubber molding, plastics testing, fluid/resin extraction, destructive testing, bonding, cell disruption, and sample preparation.
Wabash MPI and Carver’s PNP Series is a new line of pneumatic presses for a variety of applications, including composites molding, laminating, rubber molding, plastics testing, fluid/resin extraction, destructive testing, bonding, cell disruption, and sample preparation. Standard models in .5-, 2-, and 5-ton capacities and feature table-top, four-post construction. Maximum operating temperature is 500 ºF. Other standard features include low-friction seals and bearings, infinite-life framework, interchangeable cylinders along with 90-psig design pressure and five-micron particulate air filters. Optional features range from CE and cleanroom designs to platen cooling, heat tubes, 800 ºF operation, and more.
Articles in this issue
over 7 years ago
Closed Systems for Aseptic Fill and Finishover 7 years ago
Contract Packaging Growsover 7 years ago
New Kit Identifies Endonuclease Impuritiesover 7 years ago
New Size for AODD Pumpover 7 years ago
1000-Gallon Pivoting Triple Shaft Mixerover 7 years ago
Bioprocessing Facilities and FDA Inspection Problemsover 7 years ago
FDA Faces Challenges After Gottliebover 7 years ago
The Auditor Vs. Inspector Issueover 7 years ago
Avoiding Excipient Variabilityover 7 years ago
Working for the Greater GoodRelated to this article
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
How to test pen injector assembly interfaces from URS to FAT and SAT: verify part tracking, reject confirmation, restarts, and data transfer evidence.
Cole and Jaenisch dig into AI poisoning in pharma manufacturing, how it hides in plain sight, and who should be accountable for catching it.
Mahmood Majeed, ZS, explains why measurable AI outcomes in pharma supply chain and manufacturing jumped from 29% to 53%, and how GMP limits and GxP validation shape adoption.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
Trending on Pharmaceutical Technology
1
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
2
AI Formulation: Regulators Want Data
3
AAPS PharmSci 360 2026: IND-Enabling Studies vs Animal Data
4
PharmTech Weekly Roundup—October 23, 2026: CMC Considerations, Rare Disease Development, Standards Harmonization
5